Arsenox 1MG Injection (10ml) is a pharmaceutical preparation containing Arsenic Trioxide at a concentration of 1mg/ml, primarily used in the treatment of specific types of cancer, particularly acute promyelocytic leukemia (APL). This medication is administered via injection and is known for its potent anti-cancer properties. Arsenic trioxide works by inducing apoptosis, or programmed cell death, in malignant cells, thereby helping to reduce tumor size and improve patient outcomes. The formulation is designed for intravenous use, ensuring rapid absorption and effectiveness. Arsenox is typically prescribed under the supervision of healthcare professionals, who monitor the patient’s response to treatment and adjust dosages as necessary. Its unique mechanism of action and composition make it a critical component in the therapeutic arsenal against certain hematological malignancies.